Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $17.0600 (10.42%) ($15.5600 - $17.3200) on Tue. Nov. 5, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.16% (three month average) | RSI | 64 | Latest Price | $17.0600(10.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 2.2% a day on average for past five trading days. | Weekly Trend | HALO advances 1.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(54%) IWO(54%) IWM(49%) IWC(48%) XBI(48%) | Factors Impacting HALO price | HALO will decline at least -1.08% in a week (0% probabilities). VIXM(-37%) VXX(-19%) UUP(-6%) TLT(-3%) IGOV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.08% (StdDev 2.16%) | Hourly BBV | 0 () | Intraday Trend | 8.9% | | | |
|
5 Day Moving Average | $15.75(8.32%) | 10 Day Moving Average | $15.5(10.06%) | 20 Day Moving Average | $15.56(9.64%) | To recent high | -0.5% | To recent low | 14.3% | Market Cap | $2.332b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |